PNS

Provider Network Solutions Expands The Administration and Optimization of Healthcare Services to the Texas Market

Retrieved on: 
Tuesday, March 12, 2024
Insurance, Public Relations, Investor Relations, Communications, Professional Services, Hispanic, Asian American, Health, Consumer, General Health, PR, Organization, Entrepreneurship, PCP, PNS, Architecture, MPH, Medicaid, Medicare, Nursing

Provider Network Solutions (PNS) and Provider Network Solutions of Puerto Rico (PNS PR) have joined forces to create Provider Network Solutions Texas (PNS Texas), a new entity poised to make a significant impact with primary care providers in Fort Bend, Harris, and Montgomery Counties, gradually expanding the scope of services to the entire Texas territory.

Key Points: 
  • Provider Network Solutions (PNS) and Provider Network Solutions of Puerto Rico (PNS PR) have joined forces to create Provider Network Solutions Texas (PNS Texas), a new entity poised to make a significant impact with primary care providers in Fort Bend, Harris, and Montgomery Counties, gradually expanding the scope of services to the entire Texas territory.
  • “Our commitment at Provider Network Solutions is to continue to grow our organization nationwide, facilitating enhanced offerings and creating innovative solutions for healthcare providers, one market at a time,” said Dr. Jose Pelayo, CEO and Co-Founder.
  • With a combined legacy of three decades, Provider Network Solutions and Provider Network Solutions of PR, leading Value-Based healthcare organizations, are uniting to establish a strong presence and deliver high-quality care to the Texas community.
  • “We are confident that our strategic partners will deliver an initiative-taking PCP risk navigation approach and member-centric excellence,” affirmed Martha Pelayo, Vice President of Operations.

JA Solar Donates Iftar Meals to Underprivileged Solar Workers in UAE

Retrieved on: 
Wednesday, March 27, 2024
Social responsibility, Hunger, SDG2, Sustainable Development Goals, United Nations, JA Solar Holdings, Patient, Meal, PNS, Poverty, Sustainable Development Goal 1, United, International Patient Safety Goals, Student, Renewable energy

BEIJING, March 27, 2024 /PRNewswire/ -- During the Ramadan month in the Middle East, JA Solar, together with its strategic partner Power n Sun(PNS), donated iftar meals to underprivileged people working in solar sites in the UAE, as part of the company's efforts to support the United Nations' SDG1 (No Poverty) and SDG2 (Zero Hunger) initiatives.

Key Points: 
  • BEIJING, March 27, 2024 /PRNewswire/ -- During the Ramadan month in the Middle East, JA Solar, together with its strategic partner Power n Sun(PNS), donated iftar meals to underprivileged people working in solar sites in the UAE, as part of the company's efforts to support the United Nations' SDG1 (No Poverty) and SDG2 (Zero Hunger) initiatives.
  • This generous initiative has been warmly welcomed and appreciated by the recipients.
  • Throughout Ramadan, JA Solar volunteers played an integral role in the charity initiative by actively engaging in organizing and distributing the meals.
  • JA Solar is committed to corporate social responsibility and supporting the United Nations' SDGs with practical actions.

JA Solar Donates Iftar Meals to Underprivileged Solar Workers in UAE

Retrieved on: 
Wednesday, March 27, 2024
Social responsibility, Hunger, SDG2, Sustainable Development Goals, United Nations, JA Solar Holdings, Patient, Meal, PNS, Poverty, Sustainable Development Goal 1, United, International Patient Safety Goals, Multimedia, Student, Renewable energy

BEIJING, March 27, 2024 /PRNewswire/ -- During the Ramadan month in the Middle East, JA Solar, together with its strategic partner Power n Sun(PNS), donated iftar meals to underprivileged people working in solar sites in the UAE, as part of the company's efforts to support the United Nations' SDG1 (No Poverty) and SDG2 (Zero Hunger) initiatives.

Key Points: 
  • BEIJING, March 27, 2024 /PRNewswire/ -- During the Ramadan month in the Middle East, JA Solar, together with its strategic partner Power n Sun(PNS), donated iftar meals to underprivileged people working in solar sites in the UAE, as part of the company's efforts to support the United Nations' SDG1 (No Poverty) and SDG2 (Zero Hunger) initiatives.
  • Throughout Ramadan, JA Solar volunteers played an integral role in the charity initiative by actively engaging in organizing and distributing the meals.
  • JA Solar is committed to corporate social responsibility and supporting the United Nations' SDGs with practical actions.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/ja-solar-donates-iftar-meals-to...
    SOURCE JA Solar Technology Co., Ltd.

Nalu Medical, Inc. Closes $85 Million Series E Round

Retrieved on: 
Tuesday, March 5, 2024
Neurology, Biotechnology, Nanotechnology, Surgery, Health, Medical Devices, Health Technology, Technology, Pura, Medicine, Neuropathic pain, PNS, General partnership, Physician, Novo, Spinal cord stimulator, Standard of care, Health care, Chronic pain, Patient, SCS

Nalu Medical, Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-pharmacologic solutions for chronic neuropathic pain, announced today the closing of an incremental $20M in equity financing from new investor B Capital, bringing the total Series E round of equity investment to $85M.

Key Points: 
  • Nalu Medical, Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-pharmacologic solutions for chronic neuropathic pain, announced today the closing of an incremental $20M in equity financing from new investor B Capital, bringing the total Series E round of equity investment to $85M.
  • Series E was led by Novo Holdings (Novo) with $65M of the total closing in late-December 2023.
  • Also participating in the round were all existing significant investors: Gilde Healthcare, MVM Partners, Endeavour Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida, and Aperture Venture Partners.
  • “The Nalu Team is committed to addressing the unmet needs of patients suffering from chronic intractable neuropathic pain.

SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System

Retrieved on: 
Thursday, February 1, 2024
SPRINT, Growth, Chronic pain, SPR, PNS, Knee, Patient, Pain, Shoulder, Head, Investment, Venture round, Neck, Medtech, Therapy, Quality of life

The equity financing was led by Revelation Partners, SPR’s lead investor of the Series D equity financing, and incumbent investors, RC Capital and Mutual Capital Partners.

Key Points: 
  • The equity financing was led by Revelation Partners, SPR’s lead investor of the Series D equity financing, and incumbent investors, RC Capital and Mutual Capital Partners.
  • The debt facility is provided by SLR Capital Partners and Armentum Partners served as the Company’s financial advisor.
  • The funds will be used to capitalize on commercial momentum, customer demand, and market opportunity to expand SPR sales representation in additional U.S. sales territories.
  • “We thank our financing partners and are pleased to raise additional capital to support and accelerate our already significant growth,” said Maria Bennett, President, CEO and Founder of SPR Therapeutics.

Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence

Retrieved on: 
Thursday, January 18, 2024
Freedom, Patient, PNS, Sure, Collection, Partnership, Pain management, Chronic pain, Physician, Nursing

Curonix’s Freedom® Peripheral Nerve Stimulation (PNS) provides lasting chronic pain relief through a non-opioid, minimally invasive implanted technology.

Key Points: 
  • Curonix’s Freedom® Peripheral Nerve Stimulation (PNS) provides lasting chronic pain relief through a non-opioid, minimally invasive implanted technology.
  • Paired with Sure Med’s digital health platform, Perspectives in Care, Curonix will partner with physicians and their teams to collect and analyze PNS data to expand the body of clinical evidence to further support PNS efficacy.
  • Sure Med partners with forward-thinking companies to work toward solutions to help end the opioid overdose epidemic through greater compliance in pain management settings.
  • “There is a need for clinical data and outcomes to make it easier for physicians and patients to navigate a patient's chronic pain journey,” said John Bowman, Founder and CEO of Sure Med Compliance.

Nalu Medical, Inc. Presents Long-term and Holistic Outcomes from the COMFORT RCT for PNS at NANS 2024

Retrieved on: 
Tuesday, January 23, 2024
Neurology, Biotechnology, Physical Therapy, Surgery, Health, Medical Devices, Health Technology, Clinical Trials, North American Neuromodulation Society, Patient, PNS, Spinal cord, Research, Knee, NANS, RCT, Quality of life, Shoulder, Medicine, Pain, Spinal cord stimulator, SCS, Nerve, Chronic pain, Annual general meeting, Randomized controlled trial, Nalu, Physician, Pharmaceutical industry

The ongoing COMFORT RCT is a randomized, controlled, post-market, open-label, minimal risk, multi-center clinical study focused on evaluating the effectiveness of peripheral nerve stimulation (PNS) therapy with the Nalu Neurostimulation System to treat chronic pain in the shoulder, low back, knee, or ankle/foot.

Key Points: 
  • The ongoing COMFORT RCT is a randomized, controlled, post-market, open-label, minimal risk, multi-center clinical study focused on evaluating the effectiveness of peripheral nerve stimulation (PNS) therapy with the Nalu Neurostimulation System to treat chronic pain in the shoulder, low back, knee, or ankle/foot.
  • The study is designed to develop 3-year data to demonstrate the sustained pain relief and quality of life improvements achievable with the Nalu PNS system.
  • In the COMFORT RCT, we are measuring variables that present this broader picture.
  • “The COMFORT RCT is intended to provide reliable evidence of the sustained effectiveness and impact on quality of life provided by Nalu PNS therapy and to expand the use of Nalu PNS to patients for whom physicians have limited options.

SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024

Retrieved on: 
Tuesday, January 16, 2024
Permanent, Sutter Health, Assistant, Hope, Patient, PNS, Therapy, Research, NANS, Knee, Medicare, Foot, Poster, Ankle, Groin, Section, Pain, SPRINT, NP-hardness, Shoulder, CRPS, SPR, Treatment, Abstract, Physician, Nursing

CLEVELAND, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. will be featured prominently at the North American Neuromodulation Society (NANS) Annual Meeting January 18-21 in Las Vegas.

Key Points: 
  • CLEVELAND, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. will be featured prominently at the North American Neuromodulation Society (NANS) Annual Meeting January 18-21 in Las Vegas.
  • A total of 11 abstracts highlighting applications of the SPRINT® PNS System will be featured at the meeting including four posters never before presented to the industry.
  • The presentation reviews treatment costs for patients in two cohorts who started treatment either with SPRINT PNS or with a conventional brief PNS trial.
  • The poster reviews health economics and outcomes research to explore the economic implications of the use of SPRINT PNS in chronic low back pain.

Election Results for 2024 NCC Board of Directors and Officers

Retrieved on: 
Tuesday, January 9, 2024
Associate, Regis University, DNP, PNS, Assistant, NNP, State university system, Parenthood, Pharmacy, AWHONN, MSN, NCC, University, Knowledge, Neonatal nurse practitioner, A-Level, Nurse education, Committee, Wilkes University, SUNY Downstate Medical Center, WHNP-BC, National Certification Corporation, Officer, NNP-BC, Nursing credentials and certifications, Hospital, Wilkes-Barre, Pennsylvania, Women's health, Division, APRN, University of Colorado, Nursing

CHICAGO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- New & Renewed Term Appointments:

Key Points: 
  • The National Certification Corporation (NCC) is pleased to announce the outcome of the NCC Board of Directors and Officers election.
  • Directors are elected by constituents through a slate approval process and officers are appointed by the Board of Directors.
  • The full Board of Director listing is available at https://www.nccwebsite.org/NCC-Leadership.aspx
    CHICAGO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- New & Renewed Term Appointments:
    NCC welcomes the knowledge, expertise, and support of our Board of Directors.
  • Carol Wallman, DNP, APRN, NNP-BC, was re-appointed to serve as President of NCC.

Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain

Retrieved on: 
Wednesday, January 3, 2024
Technology, Medical Devices, Surgery, Seniors, Nanotechnology, Biotechnology, Physical Therapy, General Health, Consumer, Health, Pura, SCS, Novo, Chronic pain, Investment, Spinal cord stimulator, PNS, Patient, Pharmaceutical industry

Nalu Medical Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced today the closing of a $65 million equity financing.

Key Points: 
  • Nalu Medical Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced today the closing of a $65 million equity financing.
  • The proceeds from this financing will be used to accelerate commercial growth, expand clinical and health-economic evidence, continue product development, and scale operations.
  • “We continue to invest in building clinical data to expand access for patients who often don’t have other therapeutic options.
  • Novo’s investment in Nalu reflects that progress and the confidence they share in the strong commercial potential for Nalu,” observed Geoff Pardo of Gilde Healthcare and Chairman of the Nalu Board.